Sign in Subscribe

screening-procedure

A collection of 109 issues

AHN researchers help develop blood test that detects colorectal cancer and high-risk polyps

Skip to content The CRC Digest ▪ SCREENING AHN researchers help develop blood test that detects colorectal cancer and high-risk polyps Researchers at Allegheny Health Network contributed to development of a blood-based screening test capable of detecting both colorectal cancer and high-risk polyps. (Beaver County Radio) This content is informational only

Systematic review identifies factors affecting cancer screening participation among survivors

Skip to content The CRC Digest Systematic review identifies factors affecting cancer screening participation among survivors A meta-analysis examined predictors of participation in breast and colorectal cancer screening among cancer survivors, who are at increased risk of subsequent primary cancers but show suboptimal screening uptake. (Journal of Cancer Survivorship) This

Blood test shows promise for detecting advanced adenomas and colorectal cancer

Skip to content The CRC Digest ▪ SCREENING Blood test shows promise for detecting advanced adenomas and colorectal cancer The DENEB study developed and evaluated a novel blood-based assay designed to detect both advanced adenomas and colorectal cancer, addressing a key limitation of current blood tests by targeting premalignant lesions essential

Cancer Survivors Face Elevated Risk of Developing Colorectal Cancer

Skip to content The CRC Digest ♥ LIVING WITH CRC Cancer Survivors Face Elevated Risk of Developing Colorectal Cancer A Canadian cohort study of 172,928 non-colorectal cancer survivors found they have an elevated risk of developing subsequent primary colorectal cancers compared to the cancer-free population, suggesting tailored screening approaches may

13-Year NordICC Data Show Colonoscopy Reduces CRC Incidence but Not Mortality

Skip to content The CRC Digest ▪ SCREENING 13-Year NordICC Data Show Colonoscopy Reduces CRC Incidence but Not Mortality Long-term follow-up from the NordICC trial comparing colonoscopy to no screening found a reduction in colorectal cancer incidence but no statistically significant mortality benefit at 13 years. (Gastroenterology) This content is informational

13-year NordICC trial data

Skip to content The CRC Digest ▪ SCREENING 13-year NordICC trial data (Gastroenterology) This content is informational only and does not constitute medical advice. Always consult your oncologist or care team. © 2026 The CRC Digest — crcdigest.com

National study examines surveillance colonoscopy in Lynch syndrome patients

Skip to content The CRC Digest ▪ SCREENING National study examines surveillance colonoscopy in Lynch syndrome patients A national study of 4,732 Lynch syndrome carriers in the English NHS assessed adherence to surveillance guidelines and aimed to determine the impact of colonoscopic surveillance on colorectal cancer incidence and mortality in

Shared Decision-Making Framework for CRC Screening Choices

Skip to content The CRC Digest Shared Decision-Making Framework for CRC Screening Choices A review emphasizes the importance of tailoring screening strategies to individual patient risk profiles and using shared decision-making to guide patients through screening choices based on age, family history, comorbidities, and psychosocial factors. (Clinical Colon and Rectal

FDA approves second blood test to help close colorectal cancer screening gap

Skip to content The CRC Digest ● REGULATORY FDA approves second blood test to help close colorectal cancer screening gap The FDA has approved a second blood-based screening test for colorectal cancer, expanding options for patients who may avoid traditional colonoscopy. (AOL.com) This content is informational only and does not

Stool DNA Tests Offer Higher Sensitivity but Lower Specificity Than FIT

Skip to content The CRC Digest Stool DNA Tests Offer Higher Sensitivity but Lower Specificity Than FIT Multitarget stool DNA tests show higher sensitivity for colorectal cancer and advanced adenomas than FIT, but with lower specificity and higher costs; further evidence is needed on long-term effectiveness and economic sustainability. (Clinical